Enanta Pharmaceuticals
ENTA
#8175
Rank
A$0.50 B
Marketcap
A$17.39
Share price
-2.18%
Change (1 day)
0.95%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2026 : A$0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has A$0.14 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$A$97.89 M-47.44%
2024-09-30$A$0.18 B-44.76%
2023-09-30$A$0.33 B-32.51%
2022-09-30$A$0.49 B-9.56%
2021-09-30$A$0.55 B-13.11%
2020-09-30$A$0.63 B-7.18%
2019-09-30$A$0.68 B25.67%
2018-09-30$A$0.54 B41.73%
2017-09-30$A$0.38 B8.8%
2016-09-30$A$0.35 B4.91%
2015-09-30$A$0.33 B98.01%
2014-09-30$A$0.17 B43.55%
2013-09-30$A$0.11 B179.39%
2012-09-30$A$42.42 M88.24%
2011-09-30$A$22.53 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$122.09 B 83,973.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$60.27 B 41,402.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-A$8.47 Billion-5,925.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$29.09 B 19,933.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$60.32 B 41,440.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$32.07 B 21,983.15%๐Ÿ‡บ๐Ÿ‡ธ USA